0001962918-24-000036.txt : 20240403
0001962918-24-000036.hdr.sgml : 20240403
20240403181801
ACCESSION NUMBER: 0001962918-24-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240403
DATE AS OF CHANGE: 20240403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lin Shao-Lee
CENTRAL INDEX KEY: 0001725092
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41696
FILM NUMBER: 24820638
MAIL ADDRESS:
STREET 1: C/O ACELYRIN, INC.
STREET 2: 4149 LIBERTY CANYON RD.
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELYRIN, Inc.
CENTRAL INDEX KEY: 0001962918
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 852406735
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4149 LIBERTY CANYON RD.
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 805-871-4300
MAIL ADDRESS:
STREET 1: 4149 LIBERTY CANYON RD.
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
4
1
wk-form4_1712182665.xml
FORM 4
X0508
4
2024-04-01
0
0001962918
ACELYRIN, Inc.
SLRN
0001725092
Lin Shao-Lee
C/O ACELYRIN, INC.
4149 LIBERTY CANYON RD.
AGOURA HILLS
CA
91301
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-04-01
4
S
0
9961
6.6283
D
1577374
D
Common Stock
487205
I
See footnote
Common Stock
677813
I
See footnote
Common Stock
354969
I
See footnote
Common Stock
349898
I
See footnote
Common Stock
5070
I
See footnote
The sale reported on this Form 4 was effected pursuant to the Issuer's policy requiring sell-to-cover to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain Restricted Stock Units, and does not represent a discretionary sale by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $6.655 and no less than $6.600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares held directly by Shao-Lee Lin 2020 Gift Trust Dtd 7/16/20, for which the Reporting Person's spouse serves as trustee.
Shares held directly by Shao-Lee Lin, Trustee of the Shao-Lee Lin Trust u/a/d September 23, 2005, for which the Reporting Person serves as trustee.
Shares held directly by Lin Family 2020 Gift Trust Dtd 7/16/20, for which the Reporting Person's spouse shares voting and investment power.
Shares held directly by Susie Jun 2020 Gift Trust dtd 7/16/20, for which the Reporting Person serves as trustee.
Shares held directly by Susie Jun, Trustee of the Susie Jun Trust U/A/D September 23, 2005, for which the Reporting Person's spouse serves as trustee.
/s/ Mina Kim, Attorney-in-fact
2024-04-03